USAID Tamatisha TB
USAID Tamatisha TB
Overview
Despite the advancements it has made in fighting tuberculosis (TB) in recent years, Kenya has struggled to maintain that progress and meet the ambitious targets set forth in the global End TB Strategy. Many people with TB remain undiagnosed, while access and adherence to care continue to present challenges. These gaps in diagnostic and treatment services lead to higher TB incidence and increase the risk of morbidity and mortality.
In a sub-recipient role, MSH will help implement the USAID Tamatisha TB Activity—a five-year project that aims to strengthen Kenya’s health system and capacity to achieve sustainable, quality TB control. We are partnering with Centre for Health Solutions–Kenya, a local not-for-profit organization that will serve as the prime on this project, to improve TB detection, treatment, and prevention services. This partnership, along with our close collaboration with national and county governments, will ensure this work builds on existing, locally led efforts to end TB and help further tailor our approach to meet the unique needs of the 16 Kenyan counties in which we are providing deep-focused support. MSH will leverage our expertise to promote data-driven decision-making, build health workforce capacity, institutionalize active drug safety monitoring, and provide technical assistance for overall health systems strengthening.
The project will focus on the following:
- Strengthening pharmaceutical management systems for TB commodities
- Improving quality of care for TB patients
- Enhancing laboratory commodity management
- Strengthening capacity and sustainability for TB control
Fact Sheet: The Challenge of Tuberculosis
The number of new TB cases worldwide has been declining steadily in recent years. However, the burden remains high among low-income and marginalized populations. MSH develops innovative strategies to bring diagnostic, preventive, and treatment services to high-risk populations.
Management Sciences for Health Partners with Kenyan Organization to Reduce TB
The five-year project, known as USAID Tamatisha TB, will work with national and county governments to increase detection, enhance treatment success, strengthen prevention measures (particularly among high-risk populations), and increase capacity and sustainability for TB control.
Ndinda Kusu
Sub-award Program Monitor
Project Contact
Ndinda Kusu, MSH’s Program Monitor for the USAID Tamatisha TB project, is an experienced clinical pharmacist as well as a specialist in public health, program management, and health systems strengthening. She has over 25 years of experience working with the private, public, and faith-based health sectors to strengthen supply chain and pharmaceutical systems to increase access to, and the use of, medicines and health technologies for conditions such as HIV, TB, malaria, and non-communicable diseases as well as for maternal, newborn, and child health. Kusu supports supply chain, pharmaceutical, and pharmacovigilance interventions under the USAID Tamatisha TB project. She also serves as MSH’s country director for the Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program in Kenya, where she supports governance; institutional and human resource capacity development; continuous quality improvement; the promotion of the rational use of antimicrobials and efforts to curb antimicrobial resistance; and strengthening regulatory systems with a focus on post-marketing surveillance and pharmacovigilance. Kusu is a member of several health professional associations, as well as technical and advisory committees. She holds a bachelor’s degree in pharmacy from the University of Nairobi in Kenya, a master’s degree in clinical pharmacy from Queens University of Belfast, Ireland, and a master’s degree in public health from the University of Liverpool, UK.
Donors & Partners
Donors
US Agency for International Development (USAID)
Partners
Centre for Health Solutions–Kenya (CHS)
Respiratory Society of Kenya (ReSoK)
Stop TB Partnership–Kenya
Epidemic Control Systems (Epcon)